menu
    • menu

    Company profile for Seaport Therapeutics

    NEW Drugs in Dev: 6
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and dev...
    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and developing KarXT and other neuropsychiatric medicines, we are guided by an extensive network comprising renowned scientists, clinicians, and key opinion leaders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seaport TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Seaport Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://seaporttx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/seaport-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seaport's GlyphAgo Shows Positive Phase 1 MAD Trial Data
    Seaport's GlyphAgo Shows Positive Phase 1 MAD Trial Data

    08 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260608037260/en/Seaport-Therapeutics-Reports-Positive-Multiple-Ascending-Dose-Data-from-Phase-1-Proof-of-Concept-Trial-of-GlyphAgo-in-Healthy-Volunteers

    BUSINESSWIRE
    08 Jun 2026
    Share Share
    Seaport Therapeutics Reports Q1 2026 Results and Progress
    Seaport Therapeutics Reports Q1 2026 Results and Progress

    08 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260608629588/en/Seaport-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Highlights-Recent-Corporate-and-Clinical-Progress

    BUSINESSWIRE
    08 Jun 2026
    Share Share
    Seaport Therapeutics to Join Two Investor Conferences
    Seaport Therapeutics to Join Two Investor Conferences

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601692868/en/Seaport-Therapeutics-to-Participate-in-Two-Upcoming-Investor-Conferences

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    Seaport Rises 17% After $255M Upsized IPO on U.S. Markets
    Seaport Rises 17% After $255M Upsized IPO on U.S. Markets

    01 May 2026

    // BLOOMBERG

    https://www.bloomberg.com/news/articles/2026-05-01/drugmaker-seaport-climbs-17-after-255-million-upsized-us-ipo

    BLOOMBERG
    01 May 2026
    Share Share
    Seaport CEO, CSO on Karuna Lessons and the Future of CNS
    Seaport CEO, CSO on Karuna Lessons and the Future of CNS

    01 May 2026

    // ENDPOINTS

    https://endpoints.news/qa-seaport-ceo-and-cso-on-learning-from-karuna-and-the-future-of-cns-research/

    ENDPOINTS
    01 May 2026
    Share Share
    Seaport Therapeutics Prices Upsized IPO
    Seaport Therapeutics Prices Upsized IPO

    30 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260430960640/en/Seaport-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering

    BUSINESSWIRE
    30 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search